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Introduction: Poor insight, or awareness of illness, has a negative impact on the 
outcome of the psychosis, and is therefore a logical target for treatment. A meta-
analysis of the effect of psychological and pharmacological treatments on insight 
in psychosis was conducted to give a comprehensive overview of effective 
interventions. 
 
Method: n inclusive literature search (1975 - April 2012) was performed in 
PubMed, ISI Web of Science, and EMBASE. The search terms used were Insight, 
Awareness, Treatment, Psychosis, Therapy and Schizophrenia, no language 
specified. A cross-reference search of eligible articles was performed to identify 
studies not found in the computerized search. Effect sizes (Cohen’s d) of each 
study and overall were calculated under a random effects model with 95 % 
confidence intervals. 
 
Results: Our literature search resulted in approximately 350 abstracts. Nineteen 
RCTs that examined treatment effects on insight in patients with psychotic 
disorders were included. Overall, the interventions had a medium effect (d=.34, 95 
% CI, 0.120.57). The effects of CBT, adherence therapy and psycho-education 
were small to moderate, but not significant, probably due to a lack of power. 
There were insufficient data to allow a statistical evaluation of the effect of skills 
training, medication, video-confrontation and comprehensive intervention 
programs. Few adverse effects on mood were documented but this aspect was 
seldom quantified. 
 
Conclusions: There is a paucity of studies providing data regarding treatment for 
impaired insight in psychosis. Nevertheless, from the published literature in this 
meta-analysis, we can confirm that it is a potential therapeutic target and that it 
is amenable to improvement. Comprehensive intervention programs consisting of 
multiple components may be particularly promising. Improvements in insight did 
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A remarkable aspect of schizophrenia and related psychoses is that many 
patients show a striking lack of insight into their condition (Dam, 2006). Such 
reduced insight or awareness of illness is of clinical relevance. Poor insight has a 
negative impact on many relevant outcomes of the schizophrenia (David, 2004), 
such as general adjustment (Stefanopoulou et al., 2009), observer rated quality of 
life and social functioning (Drake et al., 2007) and rehospitalisation. Moreover, 
limited insight in patients often puts a strain on relationships with family-members. 
Poor treatment adherence mediates the relationship between insight and 
outcome, but there is also a direct association between insight and outcome 
(Lincoln et al., 2007). 
Clinical insight has been distinguished from cognitive insight (Beck et al., 2004). 
Clinical insight refers the awareness of having a mental disorder, being able to 
recognize the symptoms thereof and recognizing the need for treatment or help 
from others (David, 1990). Clinical insight is usually measured with self-report 
questionnaires, for example the Birchwood Insight Scale for Psychosis (Birchwood et 
al., 1994), or a semi-structured interview, e.g. the Insight and Treatment Attitudes 
Questionnaire, ITAQ (McEvoy et al., 1989); the Schedule on Assessment of Insight 
and the Schedule on Assessment of Insight Expanded, SAI, SAI-E (David, 1990; 
Kemp and David, 1996) and the Scale to assess Unawareness of Mental Disorder, 
SUMD (Amador et al., 1993). Cognitive insight involves patients’ ability to evaluate 
or distance themselves from anomalous experiences and erroneous inferences and 
is assessed with the Beck Cognitive Insight Scale, BCIS (Beck et al., 2004). 
Given the negative impact of limited insight on the outcome of schizophrenia, 
insight is a logical target for treatment. However, perhaps because improvements 
in insight are assumed to follow improvements in other domains such as reduction 
in psychotic symptoms, insight has seldom been considered as a separate 
outcome measure in treatment studies. This is unfortunate since insight has been 
shown to be relatively independent from symptoms (Mintz et al., 2003) and might 
respond in specific ways to treatment, whether it be through pharmacological, 
psychological or social means and this might go unnoticed if not considered in its 
own right. 
Another reason to consider changes in insight in relation to treatment is that 
improvements in insight may, conceivably, have unfavorable consequences. A few 
studies have suggested better insight to be associated with more depressive 
symptoms, although others find no such relationship (Lincoln et al., 2007). Even if 
the association was to be confirmed, its nature would remain unclear unless it was 
possible to separate cause and effect, that is to say, does insight lead to 
depression or vice versa? Although it remains unclear exactly how insight and 
depression may be related, many clinicians are afraid that improvements in insight 
brought about by treatment will lead to lower mood and even suicidal ideation. 
Henry and Ghaemi (2004) published a small systematic review of treatment 
interventions to improve insight in schizophrenia. Most of the interventions 
considered were not primarily developed to improve insight, but took insight into 
account as a secondary outcome measure. The main conclusion of their review 
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was that there was a paucity of informative studies. From those cited, the authors 
concluded that insight does not necessarily improve with standard treatment 
targeted at the classic symptoms of schizophrenia. 
Since this review a number of treatment studies taking insight into account have 
been published. Therefore, we felt that time was ripe for a new review of 
treatments for insight in psychosis. The aim of the present paper is to provide a 
systematic and quantitative review of the efficacy of treatment options for 
improving insight in people with psychosis. For this purpose, a meta-analysis of 
published studies on treatment for cognitive and clinical insight in schizophrenia 
was performed. A secondary aim of this meta-analysis was to examine the 
relationship between improvements in insight and depression. 
Methods 
 
Selection of studies 
 
A literature search was performed in PubMed, Psychoinfo, Picarta, Embase and ISI 
Web of Science for the years1975 through April 2012 and by conducting a 
cross-reference search of the eligible articles to identify additional studies not 
found in the electronic search. The following search terms were used: insight, 
denial, awareness, schizophrenia, psychosis, therapy and treatment and 
combinations of these. Criteria for inclusion in the meta-analysis were randomized 
controlled trials in patients with schizophrenia or another psychotic disorder. 
Moreover, insight had to be assessed with a validated measure, specified as one 
of the following instruments: the ITAQ (McEvoy et al., 1989), the SAI and SAI-E 
(David, 1990; Kemp and David, 1996), the SUMD (Amador et al., 1993), the 
Birchwood Insight Scale (Birchwood et al., 1994), item G12 of the PANSS interview 
(Kay et al., 1987) and BCIS (Beck et al., 2004). In case the paper provided 





Individual effect sizes (Cohen’s d) for control and intervention condition of each 
study were calculated with reported means and standard deviations or change 
scores using the effect size calculation software developed by Wilson (2010). 
Subsequently, effect size of the control condition was subtracted from the effect 
size of the intervention, resulting in one effect size for each study (Morris, 2008). A 
pooled standard error (SE) for each study was calculated by pooling the 
baseline standard errors of treatment and control condition (Lipsey and Wilson, 
2000). 
When two outcome measures of insight were reported, the standardized mean 
difference was based on the mean effect size of these measures (this was the case 
for David et al., 2012). Meta-analyses were performed with the program Review 
Manager 5.0, developed by the Cochrane Collaboration. Effect sizes were 
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weighted by their standard error. Because of the variance in the type of 
interventions, a random effects model was used. Overall effect size was calculated 
and represented in a forest plot together with the effect size of each study. Given 
the small number of trials and the small number of patients in most trials, we 
decided not to exclude these studies. 
Heterogeneity, or variability in outcome of studies in the meta-analysis caused by 
clinical and methodological diversity of the studies, was tested with Chi-square 
tests. Interventions were compared to either an active control condition or 
treatment as usual (TAU). To enhance the validity of the interpretation of the 
results, meta-analyses were also conducted on the total number of trials for a 
specific intervention. To examine whether effect sizes were smaller in studies with an 
active control condition, we also calculated effect sizes for placebo controlled 
studies alone. Finally, a funnel plot was made to examine whether publication bias 
on this topic was likely to be present. 
Results 
 
Our literature search resulted in 350 abstracts. When examined closely, most of 
these studies were excluded because they did not report on the effects of 
treatment on insight, a lack of randomization, or the use of a non-validated insight 
scale. Thirty studies met the inclusion criteria of the study. Of these, three were 
excluded because necessary data for meta-analysis were not provided in the 
paper, and could not be obtained upon request (Macpherson et al., 1996; 
Haddock et al., 2006; Hayward et al., 2009). One other study was excluded 
because it examined whether baseline insight predicted responsiveness to therapy 
and post-treatment data on insight where not reported (Garety et al., 1997). Four 
studies were excluded (Carroll et al., 1998; Granholm et al., 2005; Rathod et al., 
2005; Emmerson et al., 2009) because they reported on the same sample as 
another study in the selection (Cunnigham-Owens et al., 2001; Turkington et al., 
2002; Granholm et al., 2007). One additional study was excluded because it 
reported follow-up data of another study (Turkington et al., 2006). Two studies 
where omitted because they did not report post-treatment assessment (Drury et al., 
2000; O’Donnell et al., 2003). Data on insight were not reported separately in one 
study (Gray et al., 2006) but provided to us by the authors. 
Eventually, nineteen studies were selected in the treatment effect analysis, all 
published after 1997. A total of 3355 patients participated in the studies 
included in this meta-analysis (see Table 1-1, 1-2 and 1-3 for demographics of 
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Table 2. Methodological characteristics of the included trials. 
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Overall effect of treatment on insight in psychosis 
 
The mean weighted effect size of all studies on treatment-effects on insight in 
psychosis together is 0.34 (95 % CI = 0.120.57). According to Cohen’s 
nomenclature, this is a medium effect size. Fig. 1 represents the forest plot of this 
analysis. Visual inspection of the funnel plot did not reveal asymmetry; hence 
publication bias is unlikely. However, the Chi-square test was statistically 
significant, which indicates heterogeneity of intervention effects. This is not 
surprising, given the different types of interventions included in this analysis. The 
manual of the Cochrane Collaboration for meta-analysis advises in case of 
heterogeneity that results should be interpreted with caution, and that further 
investigation be done by splitting the studies into subgroups and looking at the 
forest plot of the sub-analyses. Therefore, we divided the studies into seven 
categories: medication, cognitive behavioral therapy (CBT), psycho-education, 
adherence therapy, skills training, video confrontation and comprehensive 
interventions and performed a meta-analysis on categories that included three or 
more studies. Results of interventions that were evaluated in less than three studies 
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Figure 1. Meta-analysis of treatment effects on impaired insight in people with 
psychotic disorders. 
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Results for CBT, psycho-education and adherence therapy 
 
Cognitive behavior therapy 
 
Five studies reported on the effects of CBT on insight. In two studies, insight was 
reported as one of the primary outcomes (Turkington et al., 2002; Penn et al., 
2009) and in one study as a secondary outcome (Peters et al., 2010). In two 
studies insight was incorporated as a mediator for treatment responsiveness with 
regard to symptoms (Granholm et al., 2007; Premkumar et al., 2011 ). Penn et al. 
(2009) compared CBT to enhanced supportive therapy, while treatment as usual 
(TAU) was the control condition in the other studies. We calculated the mean 
effect size of these studies (Fig. 2a.1). This was small and not significant according 
to Cohen’s nomenclature (d = 0.22, 95 % CI = 0.030.47). The Chi-square test for 
heterogeneity was not significant. We performed a second meta-analysis including 
only the studies that compared CBT to TAU (Fig. 2a.2). The overall ES was 
increased, but was still not significant (d = 0.26, 95% CI = 0.030.54). 
Two studies (Turkington et al., 2002; Granholm et al., 2007) demonstrated a 
significant effect of CBT on insight. Turkington et al. (2002) compared CBT for 
psychosis for patients and their carers provided by nurses to treatment as usual. 
This was the only study that assessed clinical insight, while the other studies 
examined cognitive insight. Granholm et al. (2007) compared CBT in combination 
with social skills training in schizophrenia patients aged older than 42 years to 
treatment as usual. 
All studies reported on the effects of CBT on depression and found that 
depression was reduced with CBT. Increased insight was not associated with lower 
mood or suicidal ideation (Turkington et al., 2002; Granholm et al., 2007). 
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with social skills training in schizophrenia patients aged older than 42 years to 
treatment as usual. 
All studies reported on the effects of CBT on depression and found that 
depression was reduced with CBT. Increased insight was not associated with lower 
mood or suicidal ideation (Turkington et al., 2002; Granholm et al., 2007). 
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Figure 2a.1. Meta-analysis of treatment effects of CBT on impaired insight in 
people with psychotic disorders: overall. 
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Figure 2a.2. Meta-analysis of treatment effects of CBT on impaired insight in 
people with psychotic disorders: CBT vs TAU. 
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Five randomized controlled trials examined the effects of psychoeducation on 
clinical insight in psychosis (Ascher-Svanum and Whitesel, 1999; Merinder et al., 
1999; Cunnigham-Owens et al., 2001; Chan et al., 2007, 2009). Insight was one 
of the primary outcomes in all trials. Psycho-education was compared to TAU 
(Merinder et al., 1999; Cunnigham-Owens et al., 2001; Chan et al., 2009), a 
symptom discussion group (Ascher-Svanum and Whitesel, 1999) or ward 
occupational therapy (Chan et al., 2007). These studies yielded a moderate and 
non-significant mean size of .42 (95 % CI .13.98; Fig. 2b.1). The Chi-square test for 
heterogeneity was statistically significant. A second meta-analysis was performed 
including only the studies that compared psycho-education to TAU (Fig. 2b.2). 
The overall ES was considerably higher, but still not significant (d=.54, 95% 
CI=.031.10). 
Three studies demonstrated a significant effect of psycho-education on insight 
(Cunningham-Owens et al., 2001; Chan et al., 2007, 2009). Chan et al. (2009) 
found a large effect size for 10 sessions of psycho-education in patients in an 
early phase of schizophrenia. Chan et al. (2007) compared a didactic illness 
management program of ten sessions to occupational therapy in a group of male 
inpatients with schizophrenia. The intervention also led to a lower re-admission 
rate. Cunnigham-Owens et al. (2001) obtained a moderate size for insight with an 
intervention that consisted of a 15 min educational video and three booklets 
discussing the content of the video. In a relatively small study (Ascher-Svanum and 
Whitesel, 1999) the effect size was negative, reflecting a positive effect of the 
control condition on insight. In this study, psycho-education was compared to a 
discussion group where patients could exchange information about their illness 
with fellow patients. Merinder et al.(1999) found that an eight session 
psychoeducation program for patients and family members did not lead to better 
insight. Improvement in insight was associated with more suicidal thoughts in one 
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Figure 2b.1. Meta-analysis of treatment effects of psycho-education on impaired 
insight in people with psychotic disorders: overall. 
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Figure 2b.2. Meta-analysis of treatment effects of psycho-education on impaired 
insight in people with psychotic disorders: psycho-education vs TAU. 
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Adherence Therapy is an intervention aiming to enhance adherence with 
medication. The intervention is based on the principles of motivational 
interviewing, such as discussing the benefits and drawbacks of medication and 
exploring ambivalence towards drug treatment. Three studies fulfilled our inclusion 
criteria. Clinical insight was a secondary outcome measure in these trials and 
adherence therapy was compared to an active control condition (non-specific 
counseling, Kemp et al., 1998; health education, Gray et al., 2006) or TAU (Staring 
et al., 2010). The total effect size for adherence therapy was small (ES = 0.26, 95 
% CI = .23.76; Fig. 2c) The Chi-square test for heterogeneity was statistically 
significant, meaning that heterogeneity between studies is likely. The first study on 
adherence therapy (Kemp et al., 1998) showed a large effect of 46 sessions of 
adherence therapy on insight, in a sample of patients with psychosis. Subsequent 
studies failed to replicate these findings. Staring et al. (2010) and Gray et al. 
(2006) did not find any effect of adherence therapy on insight. The same 
inconsistency in results was observed for the primary outcome of this studies: Kemp 
et al. (1998) and Staring et al. (2010) found improved adherence, while this 
improvement was absent in Gray’s study. Finally, Kemp et al. (1998) reported 
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Figure 2c. Meta-analysis of treatment effects of adherence therapy on impaired 
insight in people with psychotic disorders. 
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Tentative results for medication, social skills training, video self-




Surprisingly, although hundreds of studies have addressed the effects of 
antipsychotics on psychosis, almost no RCTs have reported separately on 
changes in insight. We could only find one study (McEvoy et al., 2006) that 
reported on a sample of people experiencing a first episode of psychosis who 
were randomly assigned to treatment with either haloperidol or olanzapine. The 
duration of the trial was two years; insight was assessed at twelve, 24, 52 and 
104 weeks. In contrast with other studies in the meta-analysis, this study does not 
have a clear after treatment assessment, because treatment was ongoing. 
Therefore, we chose to include the effect size after twelve weeks of treatment in 
our analysis. This was closest to the mean duration of 4.3 months of the other 
interventions. Effect size (i.e. advantage of olanzapine over haloperidol) after 
twelve weeks was small .08 (95 % CI = 0.170.33) according to Cohen’s 
nomenclature. Effects sizes on other assessment times were of comparable 
magnitude. 
 
Social skills training 
 
Xiang et al. (2007) compared Liberman module Community Re-entry to   
psychoeducation in a sample of people with acute schizophrenia. The Liberman 
training had no effect on clinical insight, while performance on social functioning, 
which was the studies primary outcome, improved. The effect size for skills training 
small (ES=.09, 95 % CI = .32. 50). It could be argued that the small effect size of 
insight was caused by the choice of psycho-education as control condition. 
Indeed, there was an increase of insight in both groups, which could have masked 
effects of the training on insight. However, the absolute effect of the training on 





Video self-observation is an innovative approach towards the enhancement of 
insight. Patients were videotaped during an episode and exposed to this 
videotape when their symptoms were partially in remission. The control condition 
was watching a video that showed a either a comedy routine (Davidoff et al., 
1998) or a same sex actor displaying psychotic symptoms (David et al., 2012). 
Insight was one of the primary outcomes in both studies. The effect size is large 
but not significant (ES .89, 95 % CI = 1.02.78), because of small sample sizes and 
relatively large standard errors. The Chi-square test for heterogeneity was 
statistically significant. Davidoff et al. (1998) obtained an impressive effect-size on 
insight with video-confrontation (Fig. 2d). However, as the sample size of this study 
was very small and drop-out rate high, these results should be interpreted with 
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caution. David et al. (2012) tried to replicate these findings in a larger sample of 
people with a psychotic disorder. 
The total effect size of this intervention was not significant (Fig. 2). However, the 
effect size included in this meta-analysis was based on two outcome measures, the 
SAI-E and the ITAQ. Scores on the SAI-E improved at a trend level, while scores on 
the ITAQ did not improve with video self-observation. Depression showed a trend 
towards improvement in David et al.’s study. 
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Figure 2d. Meta-analysis of treatment effects of video self-confrontation on 
impaired insight in people with psychotic disorders. 
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Two comprehensive interventions aiming to improve insight were found. Clinical 
insight was a primary outcome in both studies. The effect size for comprehensive 
interventions is large and significant (ES .69, 95 % CI 0.151.23; Fig. 2e). 
The Chi-square test for heterogeneity was statistically significant. Guo et al. 
(2010) compared the effects of a 12-months comprehensive psychosocial 
intervention combined with medication to the effect of medication alone in a 
large sample of people in the early stage of schizophrenia. The intervention 
consisted of psychoeducation, family intervention, skills training, and cognitive 
behavior therapy. Insight was one of these secondary outcome measures of the 
intervention, together with symptom severity, treatment adherence, social 
functioning and quality of life. Primary outcome was treatment discontinuation. 
Effect size of the intervention on insight was large. 
Drop-out rates in both arms of this study were relatively high, with 33 % in the 
experimental condition and 46.8 % in the control condition. Fung et al. (2011) 
developed a self-stigma reduction program, based on the idea that self stigma is 
associated with poor insight and will therefore lead to poorer treatment 
adherence. The program encompassed psycho-education, social skills training, 
CBT, motivational interviewing and a goal attainment program consist of sixteen 
sessions that integrate these interventions and was compared to a newspaper 
reading group. The intervention did not lead to an improvement of insight, which 
was one of the primary outcome measures of this study. The positive effect size for 
this study is caused by a decrease of insight in controls. Neither of the studies 
examined effects on mood. 
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Figure 2e. Meta-analysis of treatment effects of comprehensive interventions on 
impaired insight in people with psychotic disorders. 
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The results of our meta-analysis show that there is a significant overall effect, of 
moderate magnitude, for treatments which included improvement in insight in 
psychosis. Thus, treating patients with specific interventions can improve insight 
over and above treatment as usual. However, the overall effect size should be 
interpreted with caution, as there was substantial variance in both the nature of 
the interventions and their methodology. Moreover, the fact that interventions that 
are the experimental condition in some studies are part of TAU in others may make 
the overall ES difficult to interpret. 
We therefore conducted sub-analyses for several types of intervention, which may 
enable more meaningful conclusions. Seven categories of interventions were 
identified, of which three encompassed at least 3 studies (CBT, psycho-education 
and adherence therapy). None of these three interventions yielded a significant 
ES. The ES for CBT was small, and increased when only studies that compared CBT 
to TAU were included. While clinical insight was used as an outcome in all other 
categories, the majority of CBT studies that took insight into account focused on 
cognitive insight. The one study that examined the effects of CBT on clinical insight 
found a significant improvement. This is in line with a study by Haddock et al. 
(2006), which was not included in this meta-analysis due to a lack of statistical 
information. 
The contrast between the relatively small number of studies that report on the 
effects of CBT on insight with the wealth of reports on CBT in psychosis is striking. 
Apparently, improving insight is not the main goal in most studies and/or an effect 
of CBT on insight was not expected. This is surprising, if one realizes that an 
explicit aim of CBT in psychosis is to reappraise symptoms of the disease, which is 
seen as one of the core features of clinical insight in psychosis (David, 1990). 
Certainly, more studies on the effects of CBT on clinical insight are needed. 
There was no significant effect of psycho-education on insight, which may be due 
to a lack of power, as effect sizes were of a moderate magnitude. Two out of five 
studies reported negative results. An additional study, that was left out of the 
meta-analysis because sufficient information was lacking, did show a positive 
effect of psychoeducation on insight (Macpherson et al., 1996). In one study 
(Ascher-Svanum and Whitesel, 1999), this was because of an effect of the control 
condition an insight. However, leaving this out of the meta-analysis did not lead 
to a significant total ES.  
The authors of the other negative study (Merinder et al., 1999) concluded that 
their intervention was probably too short to bring about changes in relevant 
outcomes. This explanation does not seem likely, as the study in this category with 
the largest ES (Chan et al., 2009) concerned a program of only two more sessions. 
However, the latter study included only patients with acute schizophrenia. 
Probably the effects of psycho-education are larger in the acute phase, because 
the majority of patients will have little knowledge about psychosis at onset which 
leaves more room for improvement. 
Although adherence therapy seemed promising after the first study on this 
intervention, result have not been replicated and warrant the conclusion that 
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adherence therapy does not have an effect on insight. This is striking, as later 
intervention lasted considerably longer than Kemp et al.’s intervention (1998). 
However, while the patients in the Kemp et al. study were more acute they 
included patients with affective psychosis, who may have benefitted more from 
adherence therapy than patients with non-affective psychotic disorders. The other 
categories were too small to draw valid conclusions about the effectiveness of 
these interventions and should therefore be interpreted very cautiously. 
For medication we could include only one study, which is not sufficient to evaluate 
the effects of medication on insight in a reliable way. This study showed that the 
benefits of olanzapine did not outweigh the effects of haloperidol. Olanzapine 
would be expected to have a larger effect on insight than haloperidol, as 
olanzapine stimulates activity in the frontal lobe a brain area that has been 
associated with insight (Shad et al., 2004) more than haloperidol (Liemburg et al., 
2012). More studies are needed to get a better understanding of the effects of 
antipsychotic medication on insight. As poor insight is associated, for a small but 
significant part, with severity of psychotic symptoms (Mintz et al., 2003), it is 
conceivable that antipsychotics will at least improve insight by improving 
psychosis. A few studies have looked at the effect of clozapine on insight. They 
unfortunately did not use a randomized controlled design, but their findings 
suggest that insight may improve with atypical antipsychotic medication (Wiffen et 
al., 2010; Jong-Hoon et al., 2011). 
Two studies examined comprehensive interventions. These interventions had a 
large ES and are thus considered promising. Both programs encompassed 
psychoeducation, skills training and CBT. Guo et al. (2010) obtained a large 
effect size in acute patients, which may suggest that insight in acute patients 
improves more with treatment than in the chronic phase. The positive ES of Fung et 
al. (2011) should be interpreted cautiously as it mainly reflects a deterioration of 
insight in controls. The only study on skills training did not have an effect on 
insight, as may have been expected as a rationale for the effects of skills training 
on insight is lacking. Finally, video self-confrontation may be a way to improve 
insight in psychosis, but effects of the intervention need replication in a larger 
sample. 
Notably, in almost half of the studies that were included, insight was not the 
primary outcome. This means that even the relatively small number of studies 
included is an overestimation the number of interventions that were developed 
with the purpose of improving insight in psychosis. An important question is why 
insight is so infrequently explicitly targeted in treatment. This may be partly due to 
the fact that insight is arguably harder to operationalize than other symptoms of 
mental illness, such as hallucinations, delusions or depression. It is not even clear 
whether insight really is a unitary concept, and the etiology of poor insight is 
unclear. However, the same concerns apply to most constructs in psychiatry. 
Perhaps the main reason for the neglect of insight as a therapeutic target is that 
clinicians often see insight as an artifact of symptoms and assume that insight 
improves when symptoms remit. 
In reality, the correlations between insight and symptoms are rather modest small 
(Mintz et al., 2003). Finally, improved insight is sometimes thought to come at a 
price, namely increased depression. Contrary to this idea, we found that better 




adherence therapy does not have an effect on insight. This is striking, as later 
intervention lasted considerably longer than Kemp et al.’s intervention (1998). 
However, while the patients in the Kemp et al. study were more acute they 
included patients with affective psychosis, who may have benefitted more from 
adherence therapy than patients with non-affective psychotic disorders. The other 
categories were too small to draw valid conclusions about the effectiveness of 
these interventions and should therefore be interpreted very cautiously. 
For medication we could include only one study, which is not sufficient to evaluate 
the effects of medication on insight in a reliable way. This study showed that the 
benefits of olanzapine did not outweigh the effects of haloperidol. Olanzapine 
would be expected to have a larger effect on insight than haloperidol, as 
olanzapine stimulates activity in the frontal lobe a brain area that has been 
associated with insight (Shad et al., 2004) more than haloperidol (Liemburg et al., 
2012). More studies are needed to get a better understanding of the effects of 
antipsychotic medication on insight. As poor insight is associated, for a small but 
significant part, with severity of psychotic symptoms (Mintz et al., 2003), it is 
conceivable that antipsychotics will at least improve insight by improving 
psychosis. A few studies have looked at the effect of clozapine on insight. They 
unfortunately did not use a randomized controlled design, but their findings 
suggest that insight may improve with atypical antipsychotic medication (Wiffen et 
al., 2010; Jong-Hoon et al., 2011). 
Two studies examined comprehensive interventions. These interventions had a 
large ES and are thus considered promising. Both programs encompassed 
psychoeducation, skills training and CBT. Guo et al. (2010) obtained a large 
effect size in acute patients, which may suggest that insight in acute patients 
improves more with treatment than in the chronic phase. The positive ES of Fung et 
al. (2011) should be interpreted cautiously as it mainly reflects a deterioration of 
insight in controls. The only study on skills training did not have an effect on 
insight, as may have been expected as a rationale for the effects of skills training 
on insight is lacking. Finally, video self-confrontation may be a way to improve 
insight in psychosis, but effects of the intervention need replication in a larger 
sample. 
Notably, in almost half of the studies that were included, insight was not the 
primary outcome. This means that even the relatively small number of studies 
included is an overestimation the number of interventions that were developed 
with the purpose of improving insight in psychosis. An important question is why 
insight is so infrequently explicitly targeted in treatment. This may be partly due to 
the fact that insight is arguably harder to operationalize than other symptoms of 
mental illness, such as hallucinations, delusions or depression. It is not even clear 
whether insight really is a unitary concept, and the etiology of poor insight is 
unclear. However, the same concerns apply to most constructs in psychiatry. 
Perhaps the main reason for the neglect of insight as a therapeutic target is that 
clinicians often see insight as an artifact of symptoms and assume that insight 
improves when symptoms remit. 
In reality, the correlations between insight and symptoms are rather modest small 
(Mintz et al., 2003). Finally, improved insight is sometimes thought to come at a 
price, namely increased depression. Contrary to this idea, we found that better 
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insight brought about by CBT might lead to better mood. Only one study 
(Cunnigham-Owens et al., 2001) reported a negative effect of psycho-education 
on suicidal ideation. This finding should be interpreted cautiously, as the total 
score on the MADRS did not change and suicidal ideation was one of items of this 
scale. 
This meta-analysis of treatments aiming to improve insight in people with psychosis 
shows that there were relatively few studies that included insight as an outcome 
measure. Therefore, a limitation of this meta-analysis is that it encompasses a 
number of studies with a relatively small sample size or high drop-out rate, which 
may have biased the results. However, it should be noted here that the funnel plot 
did not show evidence for a publication bias. 
It could be argued that measures of subjective treatment adherence should have 
been included in this meta-analysis, since subjective adherence overlaps with 
insight according to current definitions. However, subjective adherence also 
includes aspects that have little to do with insight, such as reactions to side 
effects of antipsychotics. Moreover, the ability to re-label symptoms and general 
awareness are not assessed by measures of subjective awareness. Thus, because 
insight and subjective adherence are clearly not synonymous we decided not to 
include the impact of treatment on subjective adherence in this meta-analysis. 
Given the relevance for clinical practice, the effect of treatment type on 
subjective adherence could be addressed in future meta-analyses. 
To conclude: although the number of studies on treatment of insight in psychosis is 
limited, the available evidence supports the possibility of improving insight 
therapeutically. More specific approaches, targeted at cognitive processes 
Relevant for Insight, might be developed. Our group is currently evaluating a brief 
psychosocial intervention to improve insight in schizophrenia by stimulating self-
reflection (and reducing internalized stigma) and perspective taking: REFLEX 
(Pijnenborg et al., 2011). Metacognitive training, a group treatment that aims to 
changes cognitive biases, could also be a promising treatment strategy. A small 
and uncontrolled pilot showed improved awareness of illness in combination with 
better mood after the training (Favrod et al., 2011). The effectiveness of these 
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